Advertisement

Topics

FRAZIER Company Profile

16:46 EST 19th November 2017 | BioPortfolio

In the ever-complex world of healthcare, your partnership with a venture capital firm can truly make the difference between success and failure. At Frazier Healthcare Ventures, we understand the unique challenges and risks facing a growing entrepreneurial company in the healthcare industry because our sole focus is-and always has been-healthcare investing.
Founded in 1991 and with more than $1.2 billion of capital under management, Frazier Healthcare is one of the nation's leading providers of venture and growth equity capital to emerging healthcare companies. Having invested in more than 85 emerging healthcare companies, Frazier Healthcare is well known for its depth of experience and the technical expertise of its investment team. This experience encompasses product development and launch, clinical trial implementation and design, industry operating experience, academic research and clinical practice.

Location

601 UnionTwo Union Square
Suite 3200
Seattle
Washington
98101
United States of America

Contact

Phone: 206.621.7200
Fax: 206.621.1848


News Articles [46 Associated News Articles listed on BioPortfolio]

Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More

The CEO of a major U.S. pharmaceutical company was in the news this week, but for a change not because of the cost of drugs. Merck CEO Kenneth Frazier (pictured) was the first of what quickly became a...

Frazier follows performance

How Frazier Healthcare Partners plans to ramp up company creation. Plus: Aisling plays small ball; and new LPs flock to BioGeneration’s largest fund yet.

From the son of a janitor to CEO of Merck: Meet Kenneth Frazier,...

From the son of a janitor to CEO of Merck: Meet Kenneth Frazier, who's getting praised after leaving Trump's manufacturing council The move attracted some negative attention from President Don...

Industry In The Middle: Merck's Frazier Takes A Stand, Trump Tweets Back

The US president made what seemed to be a retaliatory statement about high drug prices after Merck CEO Ken Frazier...   

7 things to know about the pharma CEO who incurred Trump’s wrath

President Trump on Twitter took personal aim at Kenneth Frazier, CEO of Merck, after Frazier stepped down from the president's advisory council.

A pharma executive shows moral leadership: Why Ken Frazier did the right thing

Merck CEO Ken Frazier's resignation from a high-profile White House advisory panel over the killing in Charlottesville showed what real moral leadership looks like.

What You Should Know About Ken Frazier, The CEO Who Just Quit A Trump Advisory Council

To anyone familiar with the career of Merck's African-American CEO, it's no surprise that he'd take a stand against Trump's failure to denounce white supremacists in the wake of the violence in Charlo...

Trump Blasts Merck CEO After He Quits White House Panel Over Charlottesville Response

In a quick response to the announcement from Merck's chief Kenneth Frazier, the president tweeted that the decision would give Frazier “more time to LOWER RIPOFF DRUG PRICES!"

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Perceived Control and Voice Handicap in Patients With Voice Disorders.

The purpose of the study was to replicate and extend previous research on the relation between perceived present control and voice handicap and to further examine the psychometric properties of a pres...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

A Biofeedback Training in Schoolchildren With an Attention-Deficit/Hyperactivity Disorder (ADHD)

This study aims towards investigating the efficacy of a near-infrared spectroscopy (NIRS)-based neurofeedback training in a virtual reality (VR) classroom in schoolchildren with attention-...

Companies [15 Associated Companies listed on BioPortfolio]

Frazier Healthcare

Founded in 1991, Frazier Healthcare is a leading provider of growth equity and venture capital to high growth and emerging healthcare service, biopharma and medical device compani...

Frazier Healthcare Partners

Founded in 1991, Frazier Healthcare Partners is a leading provider of growth capital to healthcare companies. The firm has over $2.4 billion in committed capital under management ...

FRAZIER

In the ever-complex world of healthcare, your partnership with a venture capital firm can truly make the difference between success and failure. At Frazier Healthcare Ventures, we understand the uniqu...

Atterocor, Inc.

Atterocor is a drug development company focused on novel therapies for adrenal cancer. The Company launched in 2012 with a Series A financing led by top-tier life sciences investo...

Stromedix, Inc.

Stromedix is a privately held biotechnology company based in Cambridge, Massachusetts, focused on innovative therapies for fibrotic organ failure. Investors in Stromedix include A...

More Information about "FRAZIER" on BioPortfolio

We have published hundreds of FRAZIER news stories on BioPortfolio along with dozens of FRAZIER Clinical Trials and PubMed Articles about FRAZIER for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FRAZIER Companies in our database. You can also find out about relevant FRAZIER Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record